# Celecoxib for Pediatric Adenotonsillectomy

> **NCT00849966** · PHASE2 · COMPLETED · sponsor: **Children's Hospital of Eastern Ontario** · enrollment: 282 (actual)

## Conditions studied

- Tonsillectomy
- Adenotonsillectomy
- Pain, Postoperative

## Interventions

- **DRUG:** Celebrex suspension
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00849966
- **Lead sponsor:** Children's Hospital of Eastern Ontario
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2012-08
- **Final completion:** 2012-12
- **Target enrollment:** 282 (ACTUAL)
- **Last updated:** 2013-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00849966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00849966, "Celecoxib for Pediatric Adenotonsillectomy". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00849966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*